Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 banner; removed the previous government-funding operating-status notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T14:22:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, and a government funding/status notice was added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:27:08.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI updates include adding a Show glossary option, adjusting wording for Last Update Submitted that Met QC Criteria, correcting capitalization of No FEAR Act data, and updating the Revision to v3.4.0. These are cosmetic metadata changes that do not modify study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:16:42.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision history updated from v3.3.3 to v3.3.4. This change does not affect the study data or pages beyond metadata.
    Difference
    0.1%
    Check dated 2026-01-14T02:08:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Study locations were reorganized to include California, Michigan, New York, and Rhode Island under a consolidated Locations section, replacing the previous per-state headings. This update corresponds to revision 3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T09:43:05.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision note added: v3.3.2 replaces v3.2.0 on the page, reflecting metadata about the page update without altering the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:29:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.